Funder: National Institutes of Health

Due Dates: June 20, 2025 (New/Renewal/Resubmission/Revision) | July 15, 2025 (AIDS) | October 20, 2025 (New/Renewal/Resubmission/Revision) | November 18, 2025 (AIDS) | February 20, 2026 (New/Renewal/Resubmission/Revision) | March 17, 2026 (AIDS) | June 22, 2026 (New/Renewal/Resubmission/Revision) | July 14, 2026 (AIDS) | October 20, 2026 (New/Renewal/Resubmission/Revision) | November 17, 2026 (AIDS)

Funding Amounts: Recommended maximum: $350,000 direct costs/year (typically up to 3 years; max 5 years if well justified)

Summary: Supports multi-site feasibility clinical trials of mind and body interventions to generate data needed for future large-scale efficacy or effectiveness studies in high-priority health areas.

Key Information: Preliminary single-site feasibility data are required; applications must justify the need for a multi-site trial and cannot propose fully powered efficacy studies.